22 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

688321

Shenzhen Chipscreen Biosciences
CN¥19.88-5.4%-34.8%CN¥8.1bn/aPE91.2xn/an/a

688578

Shanghai Allist Pharmaceuticals
CN¥47.042.0%61.4%CN¥21.2bn/aPE32.8xE20.9%n/a

301089

Tuoxin Pharmaceutical GroupLtd
CN¥36.92-7.8%-31.4%CN¥4.7bn/aPE9.5xn/a1.1%

300534

Gansu Longshenrongfa Pharmaceutical IndustryLTD
CN¥7.59-8.2%-26.2%CN¥2.3bn/aPE40.7xn/a0%

603718

Shanghai Hile Bio-Technology
CN¥7.95-10.0%-27.0%CN¥5.2bn/aPE33.5xn/a0.7%

300434

Sichuan Goldstone Asia Pharmaceutical
CN¥8.26-6.3%-25.9%CN¥3.3bn/aPE13.2xn/a0%

301257

SMO ClinPlusLTD
CN¥44.66-10.7%-35.4%CN¥2.7bn/aPE20.2xn/a0.3%

2198

Guangdong Jiaying Pharmaceutical
CN¥6.64-7.8%-13.8%CN¥3.4bn/aPE72.3xn/a0%

600129

Chongqing Taiji Industry(Group)Ltd
CN¥33.15-1.2%-22.9%CN¥18.5bCN¥52.83PE22.5xE22.9%0.9%

301301

Yili Chuanning BiotechnologyLtd
CN¥9.533.0%4.0%CN¥21.2bCN¥10.60PE22.5xE10.6%1.0%

411

Zhejiang Int'l GroupLtd
CN¥10.27-2.1%-13.3%CN¥5.4bn/aPE12.9xn/a1.2%

688278

Xiamen Amoytop Biotech
CN¥65.374.9%44.9%CN¥26.6bCN¥89.20PE47.9xE29.7%0.6%

600267

Zhejiang Hisun Pharmaceutical
CN¥7.53-2.2%-30.6%CN¥9.0bCN¥7.40PE14.6xE2.7%2.3%

2370

Zhejiang Yatai Pharmaceutical
CN¥3.09-9.1%-29.3%CN¥1.9bn/aPS4.5xn/a0%

301211

Hubei Biocause Heilen Pharmaceutical
CN¥16.43-5.2%-24.5%CN¥4.7bn/aPE24.7xn/a2.0%

603168

Zhejiang Shapuaisi PharmaceuticalLtd
CN¥8.81-6.2%8.6%CN¥3.3bn/aPE41.7xn/a0.4%

603439

Guizhou Sanli PharmaceuticalLtd
CN¥14.50-3.5%-19.4%CN¥5.9bCN¥19.84PE23.3xE23.2%0.7%

2603

Shijiazhuang Yiling Pharmaceutical
CN¥19.70-1.6%-34.9%CN¥32.9bCN¥27.02PE12.2xE6.8%2.5%

600200

JiangSu WuZhong Pharmaceutical Development
CN¥10.68-14.6%33.8%CN¥7.5bCN¥9.80PS3.5xE108.1%0%

600645

Vcanbio Cell & Gene Engineering
CN¥15.63-3.5%-18.8%CN¥7.3bn/aPE55.9xn/an/a

603566

Pulike Biological Engineering
CN¥16.95-4.7%-36.5%CN¥5.7bCN¥22.60PE25.5xE24.4%3.5%

300705

Hunan Jiudian Pharmaceutical
CN¥34.95-0.4%33.5%CN¥12.1bn/aPE32.5xE25.7%0.7%
Page 1 of 1
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.